Abstract
The treatment of sexual offenders using hormonal agents and antiandrogens is an increasingly important approach to a difficult clinical problem. As the public becomes more focused on the problem of sexual offenders and particularly child molesters, the demand for longer terms of incarceration as a solution to the problem has escalated, whereas the rehabilitation and treatment component has been deemphasized. It is in this climate that the need for effective treatment approaches supported by outcome studies is essential. At least part of the problem is that the term sexual offender can mean anything from a violent sadistic predatory rapist to an inhibited exhibitionist.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abel, G. G., Barlow, D. H., Blanchard, E., and Guild, D. (1977). The components of rapists’ sexual arousal. Archives of General Psychiatry, 43, 895–903.
Abel, G. G., Blanchard, E., Becker, J., and Djenderedjian, A. (1978). Differentiating sexual aggressives with penile measures. Criminal Justice and Behavior, 5, 315–332.
Bancroft, J., Tennent, G., Loucas, K., and Cass, J. (1974). The control of deviant sexual behaviour by drugs: I. Behavioural changes following oestrogens and antiandrogens. British Journal of Psychiatry, 125, 310–315.
Barbaree, H. E., Marshall, W. L., and Lanthier, R. D. (1979). Deviant sexual arousal in rapists. Behaviour Research and Therapy, 17, 215–222.
Berlin, F. S., and Meinecke, C. F. (1981). Treatment of sex offenders with antiandrogenic medication: Conceptualization, review of treatment modalities and preliminary findings. American Journal of Psychiatry, 138, 601–607.
Blumer, D., and Migeon, C. (1975). Hormone and hormonal agents in the treatment of aggression. Journal of Nervous and Mental Disorders, 160, 127–137.
Bradford, J. M. W., (1983). Research in sex offenders. In R. L. Sadoff (Ed.), The psychiatric clinics of North America (pp. 715–733 ). Philadelphia: W. B. Saunders.
Bradford, J. M. W. (1985). Organic treatments for the male sexual offender. Behaviour Sciences and the Law, 3, 355–375.
Bradford, J. M. W., and Bourget, D. (1987). Sexually aggressive men. Psychiatric Journal of the University of Ottawa XII (3), 169–175.
Bradford, J. M. W., and McLean, D. (1984). Sexual offenders, violence and testosterone: A clinical study. Canadian Journal of Psychiatry, 29, 335–343.
Bradford, J. M. W., and Pawlak, A. (1987a). Sadistic homosexual pedophilia: Treatment with cyproterone acetate. A single case study. Canadian Journal of Psychiatry, 32, 22–31.
Bradford, J. M. W., and Pawlak, A. (1987b). The effects of cyproterone acetate on the sexual arousal patterns of pedophiles. Manuscript submitted for publication.
Bradford, J. M. W., and Pawlak, A. (in press). Double-blind placebo crossover study of cyproterone acetate in the treatment of sexual deviation-Phase 1. Canadian Journal of Psychiatry.
Bremer, J. (1959). Asexualization-A followup study of 244 cases. New York: MacMillan
Brown, W. A., and Davis, G. H. (1957). Serum testosterone and irritability in man. Psychosomatic Medicine, 37, 87.
Cooper, A. J. (1981). A placebo controlled study of the antiandrogen cyproterone acetate in deviant hypersexuality. Comprehensive Psychiatry, 22, 458–464.
Cooper, A. J., Ismail, A. A., Phanjoo, A. L., and Love, D. L. (1972). Antiandrogen (cyproterone acetate) therapy in deviant hypersexuality. British Journal of Psychiatry, 120, 59–63.
Cordoba, O. A., and Chapel, J. L. (1983). Medroxyprogesterone acetate antiandrogen treatment of hypersexuality in a paedophiliac sex offender. American Journal of Psychiatry, 140, 1036–1039.
Cremonocini, C., Viginati, E., and Libroia, A. (1976). Treatment of hirsutism and acne in women with two combinations of cyproterone acetate and ethinyloestradiol. Acta European Fertility, 7, 299–314.
Davidson, J. M., Smith, E. R., and Damassa, D. A. (1977). Comparative analysis of the roles of androgen in the feedback mechanisms and sexual behavior. In L. Martini and M. Motta (Eds.), Androgens and antiandrogens (pp. 137–149 ) New York: Raven Press.
Davidson, P. R., and Malcolm, P. B. (1985). The reliability of the rape index: a rapist sample. Behavioural Assessment, 7, 283–292.
Davies, T. D. (1974). Cyproterone acetate for male hypersexuality. Journal of International Medical Research, 2, 159–163.
Dourer, G. (1977). Sex-hormone-dependent brain differentiation and reproduction. In J. Money and H. Musaph (Eds.). Handbook of sexology II. Genetics, hormones and behaviour (pp. 227–245 ). New York: Elsevier.
Ehrenkranz, J., Bliss, E., and Sheard, M. H. (1974). Plasma testosterone: Correlation with aggressive behavior and social dominance in man. Psychosomatic Medicine, 36, 469–475.
Field, L. H. (1973). Benperidol in the treatment of sex offenders. Medicine Science and the Law, 13, 195–196.
Foote, R. M. (1944). Diethystilbestrol in the management of psychopathological states in males. Journal of Nervous and Mental Disease, 99, 928–935.
Gagne, P. (1981). Treatment of sex offenders with medroxyprogesterone acetate. American Journal of Psychiatry, 138, 644–646.
Golia, F. L., and Hodge, S. R. (1949). Hormone treatment of sexual offenders. Lancet, 1, 1006–1007.
Groth, A. N. (1979). Men who rape: The psychology of the offender, New York: Plenum.
Groth, A. N., Burgess, A. W., and Holmstrom, L. L. (1977). Rape: Power, anger and sexuality. American Journal of Psychiatry, 134, 1239–1243.
Heim, N., and Hursch, C. J. (1979). Castration for sexual offenders: Treatment or punishment? A review and critique of recent European literature. Archives of Sexual Behavior, 8, 281–304.
Heller, C. G., Laidlaw, W. M., Harvey, H. I. T., and Nelson, W. O. (1958). Effects of progestational compounds on the reproductive processes of the human male. Annals of the New York Academy of Science, 71, 649–655.
Hsueh, A. J., Peck, E. J., and Clark, J. H. (1976). Control of uterine receptor levels by progesterone. Endocrinology, 98, 438–444.
Kreuz, L. E., and Rose, R. M. (1972). Assessment of aggressive behaviour and plasma testosterone in a young criminal population. Psychosomatic Medicine, 34, 321–332.
Lan, N. C., and Katzenellenbogen, B. S. (1976). Temporal relationships between hormone receptor binding and biological responses in the uterus: Studies with short and long acting derivatives of estradiol. Endocrinology, 98, 220–227.
Langevin, R., Paitich, D., Hucker, S., Newman, S., Ramsay, G., Pope, S., Geller, G., and Anderson, C. (1979). The effect of assertiveness training, provera and sex of therapist in the treatment of genital exhibitionism. Journal of Behavior Therapy and Experimental Psychiatry, 10, 275–282.
Laschet, U., and Laschet, L. (1971). Psychopharmacotherapy of sex offenders with cyproterone acetate. Pharmakopsychiatrie Neuropsychopharmakologic, 4, 99–104.
Laschet, U., and Laschet, L. (1975). Antiandrogens in the treatment of sexual deviations of men. Journal of Steroid Biochemistry, 6, 821–826.
Le Maire, L. (1956). Danish experiences regarding the castration of sexual offenders. Journal of Criminal Law, Criminology and Police Science, 47, 295–310.
Liang, T., Tymoczko, J. L., Chan, K. M. B., Hung, H. C. and Liao, S. (1977). Androgen action: Receptors and rapid responses. In L. Martini and M. Motta (Eds.). Androgens and antiandrogens (pp. 77–89 ). New York: Raven Press.
Lipsett, M. B., (1977). Regulation of androgen secretion. In L. Martini and M. Motta (Eds)., Androgens and antiandrogens (pp. 11–19 ). New York: Raven Press.
Mainwaring, I. P. (1977). Modes of action of antiandrogens: A survey. In L. Martini and M. Motta (Eds.), Androgens and antiandrogens (pp. 151–161 ). New York: Raven Press.
Malamuth, N. M., Check, J. V. P., and Briere, J. (1986). Sexual arousal in response to aggression: Ideological, aggressive and sexual correlates. Journal of Personal and Social Psychology, 50, 330–340.
Meyer, W. J., Walker, P. J., Emory, L. E., and Smith, E. R. (1985). Physical, metabolic and hormonal effects on men of long-term therapy with medroxyprogesterone acetate. Fertility and Sterility, 43, 102–109.
Meyer-Bahlburg, H. F. L., Nat, R., Boon, D. A., Sharma, M., and Edwards, J. A. (1974). Aggressiveness and testosterone measures in man. Psychosomatic Medicine, 36, 269–274.
Money, J. (1968). Discussion of the hormonal inhibition of libido in male sex offenders. In R. Michael (Ed.), Endocrinology and human behaviour (p. 169 ). London: Oxford University Press.
Money, J. (1970). Use of androgen depleting hormone in the treatment of male sex offenders. Journal of Sex Research, 6, 165–172.
Money, J. (1972). The therapeutic use of androgen-depleting hormone. International Psychiatry Clinics, 8, 165–174.
Money, J., Wiedeking, C., Walker, P., Migeon, C., Meyer, W., and Borgaonkar, D. (1975). 47, XYY and 46, XY males with antisocial and/or sex-offending behaviour: Antiandrogen therapy plus counselling. Psychoneuroendocrinology, 1, 165–178.
Money, J. M., Wiedeking, C., Walker, P. A., and Gain, D. (1976). Combined antiandrogen and counselling program for treatment of 46, XY and 47, XYY sex offenders. In E. Sachar (Ed.), Hormones, behavior and psychopathology (pp. 105–120 ). New York: Raven Press.
Monti, P. M., Brown, W. A., and Corriveau, D. D. (1977). Testosterone and components of aggressive and sexual behavior in man. American Journal of Psychiatry, 134, 692–694.
Mothes, C., Lehnert, J., Samimi, F., Sr Ufer, J. (1971). Schering symposium uber sexual deviationen und ihre medikamentose Behandlung. Life Sciences Monograph, 2, 65.
Murray, M. A. F., Bancroft, J. H. H., Anderson, D. C., Tennent, T. G., and Carr, P. J. (1975). Endocrine changes in male sexual deviants after treatment with antiandrogens, oestrogens or tranquilizers. Journal of Endocrinology, 67, 179–188.
Naftolin, F., Ryan, K. J., and Petro, Z. (1972). Aromatization of androstenediol in the anterior hypothalamus of adult male and female rats. Endocrinology, 90, 295–298.
Neumann, F. (1977). Pharmacology and potential use of cyproterone acetate. Hormone and metabolic research, 9, 1–13.
Olweus, D., Mattsson, A., Schalling, D., and Low, H. (1980). Testosterone, aggression, physical and personality dimensions in normal adolescent males. Psychosomatic Medicine, 42, 253–269.
Ortmann, J. (1980). The treatment of sexual offenders, castration and antihormone therapy. International Journal of Law and Psychiatry, 3, 443–451.
Ortmann, J. (1984a). How castration influences on relapsing into sexual criminality among Danish males. Unpublished manuscript.
Ortmann, J. (1984b). How antihormone treatment with cyproterone acetate influences on relapsing into sexual criminality in male sexual offenders. Unpublished manuscript.
Ott, F. and Hoffet, H. (1968). The Influence of Antiandrogens on Libido, Potency, and Testicular Function. Schweizerische Medizinische Wochenschrift, 98, 1812–1815.
Persky, H., Smith, K. D., and Basu, G. K. (1971). Relation of psychologic measures of aggression and hostility to testosterone production in man. Psychosomatic Medicine, 40, 265–277.
Rada, R. T. (1978). Classification of the rapist. In R. T. Rada (Ed.), Clinical aspects of the rapist (pp. 117–132 ). New York: Grune and Stratton.
Rada, R. T., Laws, D. R., and Kellner, R. (1976). Plasma testosterone levels in the rapist. Psychosomatic Medicine, 38, 257–268.
Scaramella, T. J., and Brown, W. A. (1978). Serum testosterone and aggressiveness in hockey players. Psychosomatic Medicine, 40, 262–265.
Southren, A. L., Gordon, G. G., Vittek, J., and Altman, K. (1977). Effect of progestagens on androgen metabolism. In L. Martini and M. Motta (Eds.), Androgens and antiandrogens (pp. 263–279 ). New York: Raven Press.
Sterkmans, P., and Geerts, F. (1966). Is benperidol (RF 504) the specific drug for the treatment of excessive and disinhibited sexual behaviour? Acta Neurologica Psychiatrica (Belgique), 66, 1030–1040.
Stump, G. K. (1968). Treatment of sexual offenders in Herstedvester, Denmark: The rapists. Acta Psychiatrica Scandinavica (Suppl. 204 ), 5–61.
Stump, G. K. (1972). Castration: The total treatment. In H. L. P. Resnik and M. E. Wolfgang (Eds.), Sexual behaviors: Social, clinical and legal aspects (pp. 361–382 ). Massachusetts: Little, Brown.
Symmers, W. S. C. (1968). Carcinoma of the breast in transsexual individuals after surgical and hormonal interference with primary and secondary sex characteristics. British Medical Journal, 2, 3–85.
Tennent, G., Bancroft, J., and Cass, J. (1974). The control of deviant sexual behavior by drugs: A double-blind controlled study of benperidol, chlorpromazine and placebo. Archives of Sexual Behavior, 3, 261–271.
Walker, P. A., and Meyer, W. J. (1981). Medroxyprogesterone acetate treatment for paraphiliac sex offenders. In J. R. Hays, T. K. Roberts, and K. S. Solway (Eds.), Violence and the violent individual (pp. 353–373 ). New York: S.P. Medical and Scientific Books.
Whittaker, L. H. (1959). Oestrogens and psychosexual disorders. Medical Journal of Australia, 2, 547–549.
Wiedeking, C., Money, J., and Walker, P. A. (1979). Follow up of 11 XYY males with impulsive and/or sex-offending behavior. Psychological Medicine, 9, 287–292.
Wilson, J. D. and Foster, D. W. (1983). Introduction. In J. D. Wilson and D. W. Foster (Eds.), Textbook of endocrinology (pp 1–7 ). New York: Saunders.
Wincze, W. P., Bansal, S., and Malamud, M. (1986). Effects of medroxyprogesterone acetate on subjective arousal, arousal to erotic stimulation and nocturnal penile tumescence in male sex offenders. Archives of Sexual Behavior, 15, 293–305.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bradford, J.M.W. (1990). The Antiandrogen and Hormonal Treatment of Sex Offenders. In: Marshall, W.L., Laws, D.R., Barbaree, H.E. (eds) Handbook of Sexual Assault. Applied Clinical Psychology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0915-2_17
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0915-2_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0917-6
Online ISBN: 978-1-4899-0915-2
eBook Packages: Springer Book Archive